JD-SW
09618
XIAOMI-W
01810
BEKE-W
02423
ALI HEALTH
00241
BABA-W
09988
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ---- | -20.49%14.83B | ---- | 5.93%31.36B | ---- | 23.67%18.65B | ---- | -8.52%29.61B | ---- | 8.64%15.08B |
Special items of operating revenue | -17.74%20.28B | ---- | -27.74%6.34B | ---- | -11.82%24.66B | ---- | 7.08%8.78B | ---- | 8.14%27.96B | ---- |
Operating income | -17.74%20.28B | -20.49%14.83B | -27.74%6.34B | 5.93%31.36B | -11.82%24.66B | 23.67%18.65B | 7.08%8.78B | -8.52%29.61B | 8.14%27.96B | 8.64%15.08B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Administrative expenses | 8.99%-7.71B | ---- | 8.48%-2.57B | ---- | -2.07%-8.48B | ---- | -11.28%-2.81B | ---- | -20.11%-8.3B | ---- |
Employee expense | ---- | 12.30%-3.58B | ---- | -1.03%-7.97B | ---- | -3.09%-4.08B | ---- | -0.51%-7.89B | ---- | -16.24%-3.95B |
Impairment and provision | 551.69%114.84M | -804.31%-100.33M | 202.37%37M | 139.23%121.93M | 108.65%17.62M | 116.35%14.25M | 67.43%-36.15M | -216.58%-310.78M | -413.64%-203.68M | -129.78%-87.14M |
-Other impairment is provision | 551.69%114.84M | -804.31%-100.33M | 202.37%37M | 139.23%121.93M | 108.65%17.62M | 116.35%14.25M | 67.43%-36.15M | -216.58%-310.78M | -413.64%-203.68M | -129.78%-87.14M |
Operating interest expense | 4.87%-5.97B | 3.60%-3.98B | 1.38%-2.05B | -17.70%-8.41B | -19.30%-6.27B | -16.52%-4.13B | -11.40%-2.08B | 1.27%-7.14B | -0.25%-5.26B | -3.29%-3.55B |
Special items of operating profit | 13.43%-1.77B | 24.43%-3.94B | 47.66%-419.73M | -42.21%-6.61B | 64.97%-2.05B | -169.54%-5.21B | 51.58%-801.86M | -6.60%-4.65B | -30.96%-5.85B | -20.25%-1.93B |
Operating profit | -37.30%4.87B | -38.40%3.18B | -56.20%1.32B | -11.57%8.36B | -5.59%7.77B | -5.69%5.17B | 50.72%3.02B | -27.35%9.46B | -10.34%8.23B | -3.11%5.48B |
Share of profits of associates | ---- | 5,660.19%6.22M | ---- | -45.45%7.37M | ---- | -98.50%108K | ---- | 530.41%13.52M | ---- | 177.12%7.18M |
Special items of earning before tax | 96.70%-32.78M | ---- | 98.14%-1.22M | ---- | -6,311.80%-991.99M | ---- | -6,483.93%-65.31M | ---- | 2.79%-15.47M | ---- |
Earning before tax | -28.61%4.84B | -38.28%3.19B | -55.28%1.32B | -11.62%8.37B | -17.49%6.78B | -5.81%5.17B | 47.53%2.96B | -27.25%9.47B | -10.35%8.22B | -3.02%5.49B |
Tax | 50.42%-533.61M | 61.66%-327.72M | 82.67%-91.33M | 31.82%-1.32B | 39.22%-1.08B | 22.38%-854.83M | -15.03%-527.15M | 30.27%-1.94B | 8.71%-1.77B | 5.65%-1.1B |
After-tax profit from continuing operations | -24.49%4.31B | -33.65%2.86B | -49.33%1.23B | -6.40%7.05B | -11.52%5.7B | -1.65%4.32B | 57.17%2.43B | -26.43%7.53B | -10.79%6.44B | -2.34%4.39B |
Earning after tax | -24.49%4.31B | -33.65%2.86B | -49.33%1.23B | -6.40%7.05B | -11.52%5.7B | -1.65%4.32B | 57.17%2.43B | -26.43%7.53B | -10.79%6.44B | -2.34%4.39B |
Minority profit | -24.52%8.38M | -28.18%5.43M | -0.63%2.98M | 26.65%12.86M | 27.22%11.1M | 6.96%7.56M | -21.40%3M | 378.96%10.15M | 126.00%8.73M | 119.34%7.07M |
Profit attributable to shareholders | -24.49%4.3B | -33.66%2.86B | -49.39%1.23B | -6.45%7.03B | -11.57%5.69B | -1.66%4.31B | 57.36%2.43B | -26.56%7.52B | -11.33%6.44B | -3.29%4.38B |
Basic earnings per share | -29.69%0.45 | -38.78%0.3 | -57.14%0.12 | -9.30%0.78 | -14.67%0.64 | -5.77%0.49 | 55.56%0.28 | -31.20%0.86 | -15.73%0.75 | -5.45%0.52 |
Diluted earnings per share | -29.69%0.45 | -38.78%0.3 | -57.14%0.12 | -9.30%0.78 | -14.67%0.64 | -5.77%0.49 | 55.56%0.28 | -31.20%0.86 | -15.73%0.75 | -5.45%0.52 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Unlock the Full List